# Braintree, A part of SEBELA Pharmaceuticals – FDA Inspection, Jan 21, 2011

Source: https://www.keypedia.com/records/fda_inspections/braintree-a-part-of-sebela-pharmaceuticals/2980d372-45f6-4f29-bbd3-a2e16a160b75
Source feed: FDA_Inspections

> FDA inspection 707123 of Braintree, A part of SEBELA Pharmaceuticals, January 21, 2011. Classification: Voluntary Action Indicated (VAI). 7 citations under 21 CFR part 211. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 707123
- Company Name: Braintree, A part of SEBELA Pharmaceuticals
- Inspection Date: 2011-01-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 7

## Related Documents

- FDA Inspection 1261728 - 2025-03-07
- [FDA Inspection 1042622 - 2018-02-28](https://www.keypedia.com/records/fda_inspections/braintree-a-part-of-sebela-pharmaceuticals/717fe323-8916-49e3-b346-16040875b8a5)
- FDA Inspection 858979 - 2013-12-13
- FDA Inspection 814842 - 2013-01-14
- [FDA Inspection 639857 - 2010-01-22](https://www.keypedia.com/records/fda_inspections/braintree-a-part-of-sebela-pharmaceuticals/d29d717b-48d5-4e5e-bee4-6184a59792c0)

Company: https://www.keypedia.com/companies/braintree-a-part-of-sebela-pharmaceuticals/e32fa961-98ff-4606-8883-8c382bf240e2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c